Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

(2016) Maria Helena Rigatto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes

(2015) Ki Hwan Kwon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit

(2014) Matthaios Papadimitriou-Olivgeris et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

(2013) Felipe F. Tuon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission

(2012) M. Papadimitriou-Olivgeris et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients

(2008) S. M. Bagshaw et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION